Cargando…

Vitamin D status and blood group among severe COVID-19 patients

OBJECTIVE: Prognosis of COVID-19 infection has been indicated to be associated with vitamin D status and ABO blood group. However, owing to discrepancies and an increased number of cases globally, the findings remain unclear. This study aimed to evaluate the association between vitamin D and ABO blo...

Descripción completa

Detalles Bibliográficos
Autores principales: Aryafar, Mohamad, Gholami, Farshid, Bozorgmehr, Rama
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473361/
https://www.ncbi.nlm.nih.gov/pubmed/37663733
http://dx.doi.org/10.1097/MS9.0000000000000955
_version_ 1785100259705225216
author Aryafar, Mohamad
Gholami, Farshid
Bozorgmehr, Rama
author_facet Aryafar, Mohamad
Gholami, Farshid
Bozorgmehr, Rama
author_sort Aryafar, Mohamad
collection PubMed
description OBJECTIVE: Prognosis of COVID-19 infection has been indicated to be associated with vitamin D status and ABO blood group. However, owing to discrepancies and an increased number of cases globally, the findings remain unclear. This study aimed to evaluate the association between vitamin D and ABO blood group systems in patients with severe COVID-19. METHODS: In this cross-sectional study, COVID-19 patients referred to two hospitals in the capital of Iran, Tehran, admitted to the ICU ward due to the severity of COVID-19 were evaluated. Serum vitamin D and ABO levels were evaluated in these patients. The data obtained were statistically analyzed using SPSSv24. RESULTS: Of 305 patients, 33.1% patients had O+ blood type, 27.8% had A+ blood type and 22.4% had B+ blood type. Vitamin D deficiency was significantly associated with a mortality rate among these patients, P<0.05. The blood group of the patients was not correlated with mortality. Thirty-seven percent of the patients in the study died because of COVID-19. CONCLUSION: In our study population, mortality due to COVID-19 was significantly associated with vitamin D deficiency but not the ABO blood group. We recommend further studies in this regard that include more variable and detailed biochemical analysis.
format Online
Article
Text
id pubmed-10473361
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104733612023-09-02 Vitamin D status and blood group among severe COVID-19 patients Aryafar, Mohamad Gholami, Farshid Bozorgmehr, Rama Ann Med Surg (Lond) Original Research OBJECTIVE: Prognosis of COVID-19 infection has been indicated to be associated with vitamin D status and ABO blood group. However, owing to discrepancies and an increased number of cases globally, the findings remain unclear. This study aimed to evaluate the association between vitamin D and ABO blood group systems in patients with severe COVID-19. METHODS: In this cross-sectional study, COVID-19 patients referred to two hospitals in the capital of Iran, Tehran, admitted to the ICU ward due to the severity of COVID-19 were evaluated. Serum vitamin D and ABO levels were evaluated in these patients. The data obtained were statistically analyzed using SPSSv24. RESULTS: Of 305 patients, 33.1% patients had O+ blood type, 27.8% had A+ blood type and 22.4% had B+ blood type. Vitamin D deficiency was significantly associated with a mortality rate among these patients, P<0.05. The blood group of the patients was not correlated with mortality. Thirty-seven percent of the patients in the study died because of COVID-19. CONCLUSION: In our study population, mortality due to COVID-19 was significantly associated with vitamin D deficiency but not the ABO blood group. We recommend further studies in this regard that include more variable and detailed biochemical analysis. Lippincott Williams & Wilkins 2023-07-26 /pmc/articles/PMC10473361/ /pubmed/37663733 http://dx.doi.org/10.1097/MS9.0000000000000955 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Original Research
Aryafar, Mohamad
Gholami, Farshid
Bozorgmehr, Rama
Vitamin D status and blood group among severe COVID-19 patients
title Vitamin D status and blood group among severe COVID-19 patients
title_full Vitamin D status and blood group among severe COVID-19 patients
title_fullStr Vitamin D status and blood group among severe COVID-19 patients
title_full_unstemmed Vitamin D status and blood group among severe COVID-19 patients
title_short Vitamin D status and blood group among severe COVID-19 patients
title_sort vitamin d status and blood group among severe covid-19 patients
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473361/
https://www.ncbi.nlm.nih.gov/pubmed/37663733
http://dx.doi.org/10.1097/MS9.0000000000000955
work_keys_str_mv AT aryafarmohamad vitamindstatusandbloodgroupamongseverecovid19patients
AT gholamifarshid vitamindstatusandbloodgroupamongseverecovid19patients
AT bozorgmehrrama vitamindstatusandbloodgroupamongseverecovid19patients